PLIN2 and metabolic dysfunction-associated steatotic liver disease: This study identified a novel mechanism by which NAFLD develops in lean individuals and suggested that hepatic steatosis can be alleviated by activating Ubr1 through dietary essential amino acid supplementation (particularly leucine and isoleucine) to degrade Plin2, indicating a promising strategy for treating NAFLD in lean individuals.